GLP-1 drugs, or glucagon-like peptide-1 compounds , are representing as a substantial advance in managing hyperglycemia. These novel therapies function to boosting insulin production and inhibiting glucose output , often leading to enhanced glycemic control and potential weight reduction . Moreov… Read More